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TO THE EDITOR
The Merkel cell polyoma virus (MCV),
which is associated with Merkel cell
carcinoma (MCC), codes for two onco-
proteins termed large and small T anti-
gen (LT and sT). Although different MCC
cell lines clearly depend on the expres-
sion of MCV LT (Houben et al., 2012),
our results (complete rescue of growth
inhibition induced by an small hairpin
RNA (shRNA) targeting both of the
differentially spliced T antigens by
reexpression of only an shRNA-insensi-
tive LT) recently published in the Journal
of Investigative Dermatology suggest that
MCV-positive MCC cells do not require
the expression of sT for proliferation
(Angermeyer et al., 2013). Now, Shuda
et al. (2013) respond to this publication
with a letter stating the opposite on the
basis of their observation that one shRNA
targeting MCV sT (sh sT1.MS) induces
reduced sT expression and reduced
proliferation in two MCV-positive MCC
cell lines (MKL-1 and MKL-2), while
having no effect on a control cell line
(UISO; Shuda et al., 2013); two other
evaluated sT shRNA constructs either
lacked significant knockdown capability
or affected the growth of a control cell
line, thus suggesting off-target effects.
Moreover, as LT is essential for MCV-
MCC cells, data from the same group
showing that sT functions to stabilize LT
protein in MCC cells (Kwun et al. (2013),
Supplementary Figure S2B) would further
suggest that sT is also required. Surpri-
singly, however, such a dependency of
LT on sT expression is not supported by
the data now presented by Shuda et al.
(2013) as sT knockdown does not affect
LT expression (Shuda et al. (2013),
Figure 2a). Therefore, the conclusion
that MCV-MCC cells require sT is
based only on the growth-inhibiting
effect of the shRNA sh sT1.MS. No-
tably, cytotoxic or cytostatic off-target
effects frequently affect the interpre-
tation of RNA interference experiments
and vary between cell lines (Fedorov
et al., 2006). Thus, although the authors
demonstrate that the MCV-negative cell
line UISO is not affected by sh sT1.MS,
such effects cannot be completely ruled
out for MKL-1 and MKL-2. Interestingly,
within the data set provided by Shuda
et al. (2013) there is a clear example for
such a cell type–specific off-target effect:
the construct shRNA sT2.RH, which is
described by Shuda et al. (2013) to have
‘‘minimal (MKL-2) or no (MKL-1) sT
knockdown activity’’, completely inhibi-
ted the growth of the two MCV-positive
MCC cell lines, whereas the proliferation
of UISO was not affected at all (Shuda
et al., 2013, Figure 2). This observation
suggests that UISO may be less sensitive
toward shRNA-induced off-target growth
inhibition compared with MKL-1 and
MKL-2. Consequently, the conflicting
results presented by our two groups
indicate that further control
experiments are essential to remove
the question mark behind the title of
this letter, or establish the opposite. In
this respect, the rescue by reexpression
of the targeted protein is considered as
the ultimate proof for specificity of
shRNA effects (Kittler et al., 2005).
We were not able to achieve this
result for the sT shRNA constructs
used in our study ((Angermeyer et al.,
2013), Figure 2). Thus, it would beAccepted article preview online 12 November 2013; published online 12 December 2013
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interesting—and essential—to test
whether such a rescue is possible for
the shRNA construct sh sT1.MS.
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